Dr. Daniel Grosu

Dr. Grosu is the Founder and Managing Partner of GENOPRAXIS, LLC. He most recently served as Chief Medical Officer at Sequenom, Inc. until its acquisition by LabCorp, Inc. Previously, Dr. Grosuwas at Illumina, Inc., where he served as the Company’s first Chief Medical Officer. He established the Medical Affairs and Clinical Development functions at Illumina and led the team that performed the clinical studies for the first FDA-cleared and CE-marked next-generation sequencing (NGS) IVD platform and IVD assays. Earlier in his career, Dr. Grosu held positions of increasing responsibility at Siemens Medical Solutions, Bayer HealthCare Pharmaceuticals, and Johnson & Johnson.

He holds an MD (with Distinction in Research) from Saint Louis University School of Medicine (Missouri, USA) and an MBA from the University of Oxford (United Kingdom).

Specialties: Medical affairs, clinical development, technology assessment from a clinical perspective, advising on genomic medicine topics including non-invasive prenatal testing (NIPT), liquid biopsy, and inherited disorders.


2019 Virtual Summits Have no Admission Fee!

Experience Conference from Your Desk!

Join us for the 2019 HEALTHCARE ЯEVOLUTION Virtual Summits!